Khan Najat

EDGAR CIK 0002020969

Recursion Pharmaceuticals, Inc. - RXRX

  1. Manufacturing
  2. Chemicals
  3. Biological Products, (no Disgnostic Substances)
Officer Director
Chief R&D Commercial Officer
Direct Buys
0
$0
0 Shares
Direct Sells
2
($750,765)
-161,002 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
12/22/2025
10b5-1
12/29/2025
Sell
-124,403 @ $4.41
 ($548,592) 611,135 (-16.91%) Direct
08/18/2025
08/19/2025
Sell
-36,599 @ $5.52
 ($202,173) 668,197 (-5.19%) Direct